Newsfilter article unlocker

Enter Newsfilter article ID in the field below.
Example: https://newsfilter.io/articles/39be1bef03e66cdc886c08a2a6319c47

Retrieved article
15-12G 1 d757703d1512g.htm 15-12G 15-12G

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 15

 

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-39431

 

 

Freeline Therapeutics Holdings plc

(Exact name of registrant as specified in its charter)

 

 

Sycamore House

Gunnels Wood Road

Stevenage, Hertfordshire SG1 2BP

United Kingdom

+44 (0)1438 906870

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

American Depositary Shares, each representing fifteen ordinary shares,

Ordinary shares, nominal value £0.00001 per share *

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

 

 

*

Not for trading, but only in connection with the registration of the American Depositary Shares.

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)

  ☒

Rule 12g-4(a)(2)

  ☐

Rule 12h-3(b)(1)(i)

  ☒

Rule 12h-3(b)(1)(ii)

  ☐

Rule 15d-6

  ☐

Rule 15d-22(b)

  ☐

Approximate number of holders of record as of the certification or notice date: one

 

 

 


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Freeline Therapeutics Holdings plc. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: March 1, 2024

 

FREELINE THERAPEUTICS HOLDINGS PLC
By:  

/s/ Michael J. Parini

Name:   Michael J. Parini
Title:   Chief Executive Officer

...